Molecular mechanism of action of repurposed drugs and traditional Chinese medicine used for the treatment of patients infected with COVID-19: A systematic scoping review. May 04, 2020. DOI: 10.1101/2020.04.10.20060376.
, , et al.
he Clinical Benefits of Chinese Patent Medicines Against COVID-19 Based on Current Evidence. Pharmacol Res. 2020 May 4;104882. DOI: 10.1016/j.phrs.2020.104882.
T
J Ethnopharmacol. 2020 May 3;112932. DOI: 10.1016/j.jep.2020.112932.
Pharmacol Res. 2020 May;155:104743. DOI: 10.1016/j.phrs.2020.104743.
Chin Med. 2020 Apr 15;15:34. DOI: 10.1186/s13020-020-00317-x.
Yang Yang, Md Sahidul Islam, Jin Wang, Yuan Li, Xin Chen. Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective. Int J Biol Sci 2020; 16(10):1708-1717. DOI:10.7150/ijbs.45538.
Core Outcome Set for Clinical Trials of COVID-19 based on Traditional Chinese and Western Medicine. April 07, 2020. DOI: 10.1101/2020.03.23.20041533.
, , et al.
Outcome reporting from protocols of clinical trials of Coronavirus Disease 2019 (COVID-19): a review. March 08, 2020. DOI: 10.1101/2020.03.04.20031401.
, , et al.
Chang-quan Ling. Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2). Journal of Integrative Medicine. Volume 18, Issue 2, March 2020, Pages 87-88. DOI: 10.1016/j.joim.2020.02.004.